Metabolomics In Biomarker Discovery: Future Uses For Cancer Prevention
- 31 January 2008
- journal article
- review article
- Published by Taylor & Francis in Future Oncology
- Vol. 4 (1) , 93-102
- https://doi.org/10.2217/14796694.4.1.93
Abstract
Metabolomics is the systematic study of small-molecular-weight substances in cells, tissues and/or whole organisms as influenced by multiple factors including genetics, diet, lifestyle and pharmaceutical interventions. These substances may directly or indirectly interact with molecular targets and thereby influence the risk and complications associated with various diseases, including cancer. Since the interaction between metabolites and specific targets is dynamic, knowledge regarding genetics, susceptibility factors, timing, and degree of exposure to an agent (drug or food component) is fundamental to understanding the metabolome and its potential use for predicting and preventing early phenotypic changes. The future of metabolomics rests with its ability to monitor subtle changes in the metabolome that occur prior to the detection of a gross phenotypic change reflecting disease. The integrated analysis of metabolomics and other ‘omics’ may provide more sensitive ways to detect changes related to diseas...Keywords
This publication has 68 references indexed in Scilit:
- Genetic determinants of cancer metastasisNature Reviews Genetics, 2007
- Cancer Statistics, 2007CA: A Cancer Journal for Clinicians, 2007
- Cancer Statistics, Trends, and Multiple Primary Cancer Analyses from the Surveillance, Epidemiology, and End Results (SEER) ProgramThe Oncologist, 2007
- Diet and Cancer: Facts and ControversiesNutrition and Cancer, 2006
- Metabolomics-Based Systems Biology and Personalized Medicine: Moving Towards n = 1 Clinical Trials?Pharmacogenomics, 2006
- The impact of genomics and proteomics in the clinic: functional genetic polymorphisms and their value in response and toxicity prediction in solid tumoursAnnals of Oncology, 2006
- Metabolomic approaches to phenotype characterization and applications to complex diseasesExpert Review of Molecular Diagnostics, 2006
- The New Field Of Epigenomics: Implications for Cancer and Other Common Disease ResearchCold Spring Harbor Symposia on Quantitative Biology, 2004
- Functional genomics: lessons from yeast.Philosophical Transactions Of The Royal Society B-Biological Sciences, 2002
- Colorectal cancer prevention by non-steroidal anti-inflammatory drugs: effects of dosage and timingBritish Journal of Cancer, 1999